Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Pyros Pharmaceuticals
AddedFeb 16, 2024
UpdatedJun 18, 2026
Pyros Pharmaceuticals

Pyros Pharmaceuticals

Public

Pyros Pharmaceuticals: Developing and commercializing affordable generic drugs.

HQ
Parsippany-Troy Hills, NJ, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to make healthcare more accessible, Pyros Pharmaceuticals focuses on developing and commercializing affordable generic drugs. The company is committed to providing low-cost alternatives to expensive medications, particularly targeting rare diseases and conditions that require specialized treatment. Their market focus includes both the general public in need of cost-effective medication and healthcare providers seeking reliable generic options.

Notable figures affiliated with Pyros Pharmaceuticals include experts in pharmaceutical development and healthcare innovation. The company has garnered attention for its significant strides in the treatment of infantile spasms, emphasizing timely treatment initiation and effective dosing. Pyros Pharmaceuticals' impact is marked by its contribution to reducing healthcare costs and improving patient outcomes through its enhanced specialty pharmaceuticals.

Pyros Pharmaceuticals - Similar Companies

Solaris Pharma logo

Solaris Pharma

solaris-pharma.com

Bionpharma logo

Bionpharma

bionpharma.com

Auxilius Pharma logo

Auxilius Pharma

auxiliuspharma.com

Saptalis Pharmaceuticals logo

Saptalis Pharmaceuticals

PleoPharma logo

PleoPharma

pleopharma.com

Nuro Pharma logo

Nuro Pharma

Meitheal Pharmaceuticals logo

Meitheal Pharmaceuticals

meithealpharma.com

Petros Pharmaceuticals logo

Petros Pharmaceuticals

petrospharma.com

Manhattan Pharmaceuticals logo

Manhattan Pharmaceuticals

Vitruvias Therapeutics logo

Vitruvias Therapeutics

vitruvias.com

Pharmos logo

Pharmos

pharmoscorp.com

Coeptis Pharmaceuticals logo

Coeptis Pharmaceuticals

Amneal Pharmaceuticals logo

Amneal Pharmaceuticals

amneal.com

Syros Pharmaceuticals logo

Syros Pharmaceuticals

syros.com

Leading Pharma logo

Leading Pharma

leadingpharma.com

Pyros Pharmaceuticals - Quick Facts

Who are Pyros Pharmaceuticals' competitors?

Companies similar to Pyros Pharmaceuticals include Solaris Pharma, Bionpharma, Auxilius Pharma and Saptalis Pharmaceuticals.

When was Pyros Pharmaceuticals founded?

Pyros Pharmaceuticals was founded in 2017.

Where is Pyros Pharmaceuticals' headquarters located?

Pyros Pharmaceuticals' headquarters is located in Parsippany-Troy Hills, NJ, US.

When was Pyros Pharmaceuticals' last funding round?

Pyros Pharmaceuticals' most recent funding round was for $450k (USD) in March 2022.

How much has Pyros Pharmaceuticals raised to-date?

As of Mar 21, 2022, Pyros Pharmaceuticals has raised a total of $880k (USD).

How many employees does Pyros Pharmaceuticals have?

Pyros Pharmaceuticals has 40 employees as of Feb 5, 2024.

Pyros Pharmaceuticals - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Consumers
Main Product
  • Generic Drugs
Tags
  • Healthcare
  • Pharmaceuticals
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified